Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.12 trillion and total revenue of $105.29 billion.
Market Cap
1.12T
Revenue
105.29B
Profits
-41.72B
PE Ratio
n/a
Profit Margin
-39.62%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 118.36B | -0.67% | 686,328 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 81.49B | -0.85% | 430,101 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 52.04B | -1.38% | 739,639 | 3.21B |
| 4 | ARGX | argenx SE | 49.38B | 0.03% | 283,688 | 3.68B |
| 5 | ONC | BeOne Medicines AG | 37.26B | 5.09% | 409,192 | 4.97B |
| 6 | INSM | Insmed Incorporated | 37.17B | 2.34% | 3,561,271 | 447.02M |
| 7 | BNTX | BioNTech SE | 24.07B | 1.28% | 429,673 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.33B | 0.40% | 1,072,228 | 2.35B |
| 9 | RVMD | Revolution Medicines, Inc. | 22.31B | 7.46% | 11,235,757 | - |
| 10 | INCY | Incyte Corporation | 21.01B | 1.05% | 767,788 | 4.81B |
| 11 | GMAB | Genmab A/S | 20.66B | 1.87% | 1,033,523 | 3.85B |
| 12 | ROIV | Roivant Sciences Ltd. | 15.45B | 2.00% | 3,007,826 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 14.96B | 5.13% | 1,782,910 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 14.91B | 2.71% | 1,350,856 | - |
| 15 | MRNA | Moderna, Inc. | 13.41B | 1.39% | 4,948,173 | 2.23B |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 12.94B | -2.00% | 1,489,460 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 12.50B | -2.42% | 530,293 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 11.91B | 0.25% | 1,429,397 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.78B | -6.77% | 499,058 | 740.64M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.45B | -1.24% | 1,105,997 | 3.09B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.90B | -0.05% | 721,486 | 20.87M |
| 22 | TECH | Bio-Techne Corporation | 10.34B | 2.73% | 1,213,436 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 9.84B | 1.09% | 587,147 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.00B | -0.05% | 1,104,199 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.73B | -1.20% | 1,209,617 | 829.45M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.61B | 1.91% | 468,597 | 561.26M |
| 27 | HALO | Halozyme Therapeutics, Inc. | 8.54B | 0.69% | 995,476 | 1.24B |
| 28 | NUVL | Nuvalent, Inc. | 8.04B | 0.85% | 254,740 | - |
| 29 | CAI | Caris Life Sciences, Inc. | 8.02B | 0.62% | 919,454 | 649.06M |
| 30 | CYTK | Cytokinetics, Incorporated | 7.66B | -1.01% | 1,226,934 | 87.21M |
| 31 | KRYS | Krystal Biotech, Inc. | 7.50B | 3.90% | 176,283 | 373.16M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 7.24B | -1.70% | 262,883 | 7.46M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.69B | 2.86% | 481,161 | 174.33M |
| 34 | PTCT | PTC Therapeutics, Inc. | 6.21B | 0.60% | 790,076 | 1.78B |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.09B | 1.51% | 306,360 | 43.74M |
| 36 | BLTE | Belite Bio, Inc | 6.08B | -1.23% | 202,776 | - |
| 37 | PCVX | Vaxcyte, Inc. | 5.99B | 1.02% | 466,027 | - |
| 38 | COGT | Cogent Biosciences, Inc. | 5.41B | -0.06% | 1,305,386 | - |
| 39 | IMVT | Immunovant, Inc. | 5.37B | 0.65% | 941,511 | - |
| 40 | APGE | Apogee Therapeutics, Inc. | 5.27B | 0.72% | 314,163 | - |
| 41 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.17B | 2.25% | 896,595 | 1.54M |
| 42 | CRSP | CRISPR Therapeutics AG | 5.15B | -4.22% | 1,243,681 | 38.34M |
| 43 | PTGX | Protagonist Therapeutics, Inc. | 5.01B | -0.11% | 500,975 | 209.22M |
| 44 | CELC | Celcuity Inc. | 4.84B | -0.09% | 171,264 | - |
| 45 | GPCR | Structure Therapeutics Inc. | 4.74B | 2.42% | 714,204 | - |
| 46 | ACAD | ACADIA Pharmaceuticals Inc. | 4.50B | -1.19% | 269,767 | 1.05B |
| 47 | FOLD | Amicus Therapeutics, Inc. | 4.42B | 0.11% | 6,071,510 | 598.70M |
| 48 | MIRM | Mirum Pharmaceuticals, Inc. | 4.41B | 4.61% | 446,893 | 471.79M |
| 49 | CGON | CG Oncology, Inc. | 4.38B | 29.57% | 5,922,399 | 2.17M |
| 50 | LEGN | Legend Biotech Corporation | 4.32B | 1.56% | 2,935,770 | 909.05M |
| 51 | SRRK | Scholar Rock Holding Corporation | 4.30B | 1.18% | 480,634 | - |
| 52 | ADMA | ADMA Biologics, Inc. | 4.27B | -0.80% | 1,076,405 | 488.56M |
| 53 | TGTX | TG Therapeutics, Inc. | 4.23B | -5.05% | 1,199,305 | 531.90M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.02B | 2.05% | 77,415 | 251.23M |
| 55 | NAMS | NewAmsterdam Pharma Company N.V. | 3.99B | -1.73% | 560,234 | 35.24M |
| 56 | CORT | Corcept Therapeutics Incorporated | 3.87B | 0.79% | 880,561 | 741.17M |
| 57 | ACLX | Arcellx, Inc. | 3.84B | 3.14% | 490,632 | 35.90M |
| 58 | TERN | Terns Pharmaceuticals, Inc. | 3.82B | -6.96% | 1,971,438 | - |
| 59 | VKTX | Viking Therapeutics, Inc. | 3.63B | 1.33% | 1,739,105 | - |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 3.51B | -4.02% | 1,036,914 | 317.93M |
| 61 | VERA | Vera Therapeutics, Inc. | 3.46B | 2.20% | 493,996 | - |
| 62 | APLS | Apellis Pharmaceuticals, Inc. | 3.40B | 2.38% | 2,805,872 | 1.02B |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.27B | -1.47% | 181,793 | 366.10M |
| 64 | IDYA | IDEAYA Biosciences, Inc. | 3.27B | 2.36% | 435,274 | 214.83M |
| 65 | CNTA | Centessa Pharmaceuticals plc | 3.26B | 1.22% | 511,705 | 15.00M |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.25B | 2.13% | 1,097,975 | 7.50M |
| 67 | LQDA | Liquidia Corporation | 3.22B | 16.50% | 6,155,998 | 69.22M |
| 68 | TVTX | Travere Therapeutics, Inc. | 3.11B | -2.43% | 1,471,805 | 435.83M |
| 69 | VRDN | Viridian Therapeutics, Inc. | 2.99B | 3.25% | 862,527 | 70.79M |
| 70 | IRON | Disc Medicine, Inc. | 2.96B | -1.12% | 118,867 | - |
| 71 | DYN | Dyne Therapeutics, Inc. | 2.93B | -2.71% | 599,918 | - |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.81B | 1.28% | 597,215 | 578.20M |
| 73 | NUVB | Nuvation Bio Inc. | 2.79B | -3.61% | 3,232,828 | 26.75M |
| 74 | BEAM | Beam Therapeutics Inc. | 2.70B | -2.43% | 680,534 | 55.70M |
| 75 | DNLI | Denali Therapeutics Inc. | 2.67B | 0.18% | 513,413 | - |
| 76 | MESO | Mesoblast Limited | 2.63B | 4.73% | 249,830 | 17.20M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.62B | -0.89% | 1,711,157 | 240.00M |
| 78 | EWTX | Edgewise Therapeutics, Inc. | 2.61B | -1.20% | 440,355 | - |
| 79 | MLYS | Mineralys Therapeutics, Inc. | 2.60B | -0.81% | 716,550 | - |
| 80 | AAPG | Ascentage Pharma Group International | 2.59B | 1.36% | 832 | 54.52M |
| 81 | TLX | Telix Pharmaceuticals Limited | 2.54B | -0.63% | 50,352 | 664.23M |
| 82 | WVE | Wave Life Sciences Ltd. | 2.54B | -6.54% | 2,235,497 | 109.23M |
| 83 | SRPT | Sarepta Therapeutics, Inc. | 2.47B | 1.86% | 1,068,748 | 2.41B |
| 84 | RXRX | Recursion Pharmaceuticals, Inc. | 2.42B | -0.96% | 11,786,022 | 43.69M |
| 85 | ADPT | Adaptive Biotechnologies Corporation | 2.42B | -0.63% | 1,258,178 | 252.75M |
| 86 | OCUL | Ocular Therapeutix, Inc. | 2.38B | -1.85% | 1,418,546 | 55.78M |
| 87 | SYRE | Spyre Therapeutics, Inc. | 2.38B | 1.63% | 224,421 | - |
| 88 | IMNM | Immunome, Inc. | 2.36B | 4.40% | 1,396,494 | 9.68M |
| 89 | SLNO | Soleno Therapeutics, Inc. | 2.32B | -5.10% | 1,221,591 | 98.68M |
| 90 | IBRX | ImmunityBio, Inc. | 2.31B | 4.69% | 10,316,562 | 82.56M |
| 91 | HRMY | Harmony Biosciences Holdings, Inc. | 2.22B | 1.61% | 445,490 | 825.94M |
| 92 | OLMA | Olema Pharmaceuticals, Inc. | 2.19B | 8.64% | 1,116,113 | - |
| 93 | RARE | Ultragenyx Pharmaceutical Inc. | 2.18B | -2.28% | 1,364,018 | 630.60M |
| 94 | GLPG | Galapagos NV | 2.17B | 0.55% | 78,192 | 336.64M |
| 95 | ZLAB | Zai Lab Limited | 2.07B | 0.49% | 377,987 | 441.63M |
| 96 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | - | 524,142 | 265.81M |
| 97 | VCEL | Vericel Corporation | 1.97B | -4.12% | 334,712 | 258.72M |
| 98 | ALMS | Alumis Inc. | 1.96B | 3.03% | 3,104,853 | 22.12M |
| 99 | NRIX | Nurix Therapeutics, Inc. | 1.92B | 1.66% | 481,145 | 83.69M |
| 100 | MAZE | Maze Therapeutics, Inc. | 1.92B | 2.34% | 67,982 | 2.50M |
| 101 | STOK | Stoke Therapeutics, Inc. | 1.86B | -3.21% | 215,034 | 205.63M |
| 102 | ERAS | Erasca, Inc. | 1.86B | 12.74% | 7,426,329 | - |
| 103 | ARDX | Ardelyx, Inc. | 1.84B | 8.29% | 12,958,628 | 398.23M |
| 104 | SNDX | Syndax Pharmaceuticals, Inc. | 1.83B | -1.31% | 482,431 | 111.30M |
| 105 | MNKD | MannKind Corporation | 1.83B | -0.83% | 1,481,644 | 313.79M |
| 106 | CLDX | Celldex Therapeutics, Inc. | 1.82B | -0.02% | 289,561 | 2.60M |
| 107 | NBY | NovaBay Pharmaceuticals, Inc. | 1.79B | 49.79% | 4,402,479 | 10.30M |
| 108 | ZYME | Zymeworks Inc. | 1.73B | 0.32% | 555,212 | 134.48M |
| 109 | KOD | Kodiak Sciences Inc. | 1.70B | 3.08% | 233,008 | - |
| 110 | SION | Sionna Therapeutics, Inc. | 1.69B | 3.20% | 161,161 | - |
| 111 | PHVS | Pharvaris N.V. | 1.68B | 3.60% | 198,715 | - |
| 112 | IMCR | Immunocore Holdings plc | 1.67B | -0.12% | 167,203 | 379.59M |
| 113 | PGEN | Precigen, Inc. | 1.65B | 1.30% | 2,469,082 | 6.31M |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | 0.39% | 568,368 | 44.79M |
| 115 | DNTH | Dianthus Therapeutics, Inc. | 1.64B | 0.28% | 506,211 | 3.08M |
| 116 | FTRE | Fortrea Holdings Inc. | 1.61B | -0.17% | 1,094,210 | 2.76B |
| 117 | GLUE | Monte Rosa Therapeutics, Inc. | 1.61B | -2.53% | 4,086,313 | 181.54M |
| 118 | QURE | uniQure N.V. | 1.59B | 10.24% | 3,495,858 | 15.75M |
| 119 | UPB | Upstream Bio, Inc. | 1.58B | 5.88% | 490,748 | 2.80M |
| 120 | TYRA | Tyra Biosciences, Inc. | 1.56B | -3.89% | 254,316 | - |
| 121 | ELVN | Enliven Therapeutics, Inc. | 1.54B | 11.44% | 3,741,593 | - |
| 122 | TNGX | Tango Therapeutics, Inc. | 1.51B | 1.67% | 2,775,790 | 66.50M |
| 123 | BHVN | Biohaven Ltd. | 1.48B | -1.50% | 1,739,490 | - |
| 124 | INVA | Innoviva, Inc. | 1.47B | -0.20% | 224,231 | 388.52M |
| 125 | TRVI | Trevi Therapeutics, Inc. | 1.44B | 0.27% | 575,465 | - |
| 126 | MBX | MBX Biosciences, Inc. | 1.41B | 1.92% | 207,569 | - |
| 127 | RAPP | Rapport Therapeutics, Inc. | 1.40B | 3.74% | 91,573 | - |
| 128 | SVRA | Savara Inc. | 1.40B | 0.52% | 717,341 | - |
| 129 | MNMD | Mind Medicine (MindMed) Inc. | 1.38B | -4.39% | 1,185,010 | - |
| 130 | RLAY | Relay Therapeutics, Inc. | 1.38B | -0.38% | 527,155 | 8.36M |
| 131 | TSHA | Taysha Gene Therapies, Inc. | 1.36B | -3.70% | 1,991,970 | 6.31M |
| 132 | XERS | Xeris Biopharma Holdings, Inc. | 1.35B | 0.25% | 1,530,665 | 266.14M |
| 133 | EYPT | EyePoint, Inc. | 1.35B | -4.74% | 513,312 | 42.34M |
| 134 | ATAI | AtaiBeckley Inc. | 1.34B | -6.80% | 3,702,204 | 3.02M |
| 135 | OCS | Oculis Holding AG | 1.34B | 5.13% | 371,220 | 992.00K |
| 136 | ORKA | Oruka Therapeutics, Inc. | 1.33B | 4.09% | 296,387 | - |
| 137 | ABCL | AbCellera Biologics Inc. | 1.30B | 5.60% | 5,447,798 | 35.33M |
| 138 | MLTX | MoonLake Immunotherapeutics | 1.29B | 25.70% | 10,272,273 | - |
| 139 | PHAR | Pharming Group N.V. | 1.28B | 2.94% | 21,017 | 362.27M |
| 140 | SPRY | ARS Pharmaceuticals, Inc. | 1.27B | 17.63% | 4,486,438 | 142.77M |
| 141 | ANAB | AnaptysBio, Inc. | 1.26B | 3.70% | 262,473 | 169.47M |
| 142 | IMTX | Immatics N.V. | 1.24B | -0.54% | 240,886 | 99.45M |
| 143 | CAPR | Capricor Therapeutics, Inc. | 1.24B | -6.50% | 1,721,744 | 11.13M |
| 144 | NVAX | Novavax, Inc. | 1.20B | 0.20% | 1,641,515 | 1.06B |
| 145 | NTLA | Intellia Therapeutics, Inc. | 1.19B | -2.19% | 4,076,630 | 57.53M |
| 146 | SANA | Sana Biotechnology, Inc. | 1.19B | -1.22% | 1,362,173 | - |
| 147 | PVLA | Palvella Therapeutics, Inc. | 1.15B | -0.04% | 144,915 | - |
| 148 | SEPN | Septerna, Inc. | 1.14B | -1.52% | 125,196 | 22.05M |
| 149 | AKTS | Aktis Oncology, Inc. | 1.10B | 16.67% | 2,332,618 | 5.56M |
| 150 | PHAT | Phathom Pharmaceuticals, Inc. | 1.09B | -1.86% | 803,427 | 147.19M |
| 151 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.06B | -0.23% | 506,129 | - |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.06B | -3.09% | 64,553 | 1.40M |
| 153 | URGN | UroGen Pharma Ltd. | 1.03B | -6.65% | 285,455 | 96.52M |
| 154 | IOVA | Iovance Biotherapeutics, Inc. | 1.01B | -2.30% | 5,683,749 | 250.43M |
| 155 | MRVI | Maravai LifeSciences Holdings, Inc. | 998.54M | 1.43% | 468,964 | 192.44M |
| 156 | XNCR | Xencor, Inc. | 995.10M | -1.80% | 585,058 | 150.13M |
| 157 | BCAX | Bicara Therapeutics Inc. | 994.29M | 9.60% | 240,246 | - |
| 158 | VTYX | Ventyx Biosciences, Inc. | 984.75M | -0.29% | 9,424,804 | - |
| 159 | NBTX | Nanobiotix S.A. | 981.00M | 4.76% | 40,316 | 11.93M |
| 160 | TBPH | Theravance Biopharma, Inc. | 964.30M | 0.05% | 134,875 | 80.33M |
| 161 | CMPX | Compass Therapeutics, Inc. | 948.89M | 3.19% | 2,591,556 | 850.00K |
| 162 | DAWN | Day One Biopharmaceuticals, Inc. | 947.69M | -0.22% | 635,927 | 133.67M |
| 163 | GHRS | GH Research PLC | 924.86M | -4.12% | 318,972 | - |
| 164 | IVA | Inventiva S.A. | 909.94M | -2.03% | 123,344 | 19.93M |
| 165 | MDXG | MiMedx Group, Inc. | 901.20M | -3.57% | 668,020 | 393.44M |
| 166 | OMER | Omeros Corporation | 894.76M | -6.17% | 2,913,141 | - |
| 167 | RAPT | RAPT Therapeutics, Inc. | 890.90M | 3.04% | 179,516 | - |
| 168 | ABUS | Arbutus Biopharma Corporation | 887.58M | -0.75% | 436,372 | 14.61M |
| 169 | ZBIO | Zenas BioPharma, Inc. | 878.19M | -0.30% | 323,508 | 15.00M |
| 170 | GERN | Geron Corporation | 877.74M | 0.36% | 11,921,617 | 183.40M |
| 171 | YDES | YD Bio Limited | 868.67M | 0.19% | 40,726 | 510.36K |
| 172 | ORIC | ORIC Pharmaceuticals, Inc. | 864.82M | 5.09% | 807,000 | - |
| 173 | VALN | Valneva SE | 855.26M | 0.51% | 3,721 | 211.09M |
| 174 | AVBP | ArriVent BioPharma, Inc. | 849.57M | 4.89% | 157,852 | - |
| 175 | JANX | Janux Therapeutics, Inc. | 847.48M | 1.29% | 550,317 | 10.00M |
| 176 | KALV | KalVista Pharmaceuticals, Inc. | 839.07M | 4.93% | 4,191,284 | 1.43M |
| 177 | KURA | Kura Oncology, Inc. | 824.06M | -0.84% | 860,528 | 104.03M |
| 178 | NKTR | Nektar Therapeutics | 821.19M | -2.58% | 383,793 | 62.60M |
| 179 | VIR | Vir Biotechnology, Inc. | 813.19M | -1.76% | 846,630 | 16.86M |
| 180 | ANNX | Annexon, Inc. | 788.51M | - | 682,144 | - |
| 181 | MPLT | MapLight Therapeutics, Inc. | 786.85M | 4.89% | 74,773 | - |
| 182 | ARVN | Arvinas, Inc. | 784.82M | 0.33% | 215,591 | 312.30M |
| 183 | LXEO | Lexeo Therapeutics, Inc. | 775.13M | 12.14% | 986,829 | - |
| 184 | RIGL | Rigel Pharmaceuticals, Inc. | 748.56M | -7.33% | 429,529 | 282.08M |
| 185 | ATXS | Astria Therapeutics, Inc. | 747.53M | 0.89% | 354,287 | 706.00K |
| 186 | RGNX | REGENXBIO Inc. | 742.13M | -2.27% | 239,734 | 161.32M |
| 187 | CTMX | CytomX Therapeutics, Inc. | 733.66M | 1.64% | 1,303,310 | 113.63M |
| 188 | IVVD | Invivyd, Inc. | 719.13M | 3.39% | 2,478,171 | 50.04M |
| 189 | DBVT | DBV Technologies S.A. | 705.91M | -0.12% | 179,852 | 5.50M |
| 190 | PROK | ProKidney Corp. | 691.92M | -2.54% | 533,967 | 744.00K |
| 191 | PRME | Prime Medicine, Inc. | 691.33M | -0.38% | 1,493,245 | 5.98M |
| 192 | GYRE | Gyre Therapeutics, Inc. | 679.86M | -1.19% | 25,478 | 107.27M |
| 193 | DRUG | Bright Minds Biosciences Inc. | 672.50M | -2.57% | 99,398 | - |
| 194 | FULC | Fulcrum Therapeutics, Inc. | 660.03M | -1.04% | 415,046 | 80.00M |
| 195 | CGEM | Cullinan Therapeutics, Inc. | 638.02M | -3.05% | 441,258 | - |
| 196 | REPL | Replimune Group, Inc. | 635.39M | -1.58% | 677,898 | - |
| 197 | JBIO | Jade Biosciences, Inc. | 620.14M | 1.74% | 96,266 | - |
| 198 | CRMD | CorMedix Inc. | 619.28M | 4.66% | 5,739,254 | 214.30M |
| 199 | VSTM | Verastem, Inc. | 605.49M | -0.32% | 1,381,405 | 13.38M |
| 200 | EVMN | Evommune, Inc. | 605.26M | 5.32% | 257,383 | 13.00M |
| 201 | ENGN | enGene Holdings Inc. | 596.16M | 4.71% | 169,961 | - |
| 202 | MGTX | MeiraGTx Holdings plc | 593.22M | 1.24% | 241,443 | 27.42M |
| 203 | KROS | Keros Therapeutics, Inc. | 583.73M | 3.12% | 268,029 | 246.72M |
| 204 | DRTS | Alpha Tau Medical Ltd. | 574.68M | 5.15% | 484,111 | - |
| 205 | GOSS | Gossamer Bio, Inc. | 572.85M | -1.00% | 2,119,887 | 44.05M |
| 206 | DSGN | Design Therapeutics, Inc. | 542.29M | 3.70% | 110,841 | - |
| 207 | TENX | Tenax Therapeutics, Inc. | 538.98M | 1.26% | 210,280 | - |
| 208 | LBRX | LB Pharmaceuticals Inc | 538.11M | 2.26% | 124,222 | - |
| 209 | DNA | Ginkgo Bioworks Holdings, Inc. | 528.86M | 2.70% | 329,239 | 180.61M |
| 210 | NAGE | Niagen Bioscience, Inc. | 526.19M | 0.15% | 490,499 | 124.71M |
| 211 | LYEL | Lyell Immunopharma, Inc. | 524.73M | 1.65% | 80,304 | 41.00K |
| 212 | ANRO | Alto Neuroscience, Inc. | 517.88M | 4.91% | 142,439 | - |
| 213 | VOR | Vor Biopharma Inc. | 515.75M | 4.23% | 722,730 | - |
| 214 | CRVS | Corvus Pharmaceuticals, Inc. | 507.84M | -1.73% | 861,219 | - |
| 215 | ABSI | Absci Corporation | 503.74M | -2.62% | 6,524,577 | 2.82M |
| 216 | ASMB | Assembly Biosciences, Inc. | 496.50M | -0.54% | 69,788 | 37.19M |
| 217 | PRTA | Prothena Corporation plc | 495.24M | 1.66% | 215,901 | 11.79M |
| 218 | ZVRA | Zevra Therapeutics, Inc. | 484.72M | -0.23% | 450,683 | 84.39M |
| 219 | AUTL | Autolus Therapeutics plc | 484.38M | -4.71% | 1,553,019 | 51.13M |
| 220 | KYTX | Kyverna Therapeutics, Inc. | 479.32M | -0.71% | 394,593 | - |
| 221 | SLS | SELLAS Life Sciences Group, Inc. | 475.76M | -13.47% | 14,660,048 | - |
| 222 | LENZ | LENZ Therapeutics, Inc. | 471.85M | -1.05% | 1,125,324 | 17.50M |
| 223 | OCGN | Ocugen, Inc. | 466.92M | 0.34% | 2,144,928 | 5.37M |
| 224 | BCYC | Bicycle Therapeutics plc | 457.83M | -0.45% | 110,126 | 28.34M |
| 225 | ADCT | ADC Therapeutics SA | 451.53M | 2.10% | 339,255 | 75.21M |
| 226 | VTVT | vTv Therapeutics Inc. | 451.50M | -11.39% | 23,656 | 17.00K |
| 227 | PEPG | PepGen Inc. | 439.99M | -5.04% | 238,577 | - |
| 228 | ALT | Altimmune, Inc. | 436.62M | -1.96% | 2,161,059 | 20.00K |
| 229 | EPRX | Eupraxia Pharmaceuticals Inc. | 434.30M | -3.96% | 190,742 | - |
| 230 | VNDA | Vanda Pharmaceuticals Inc. | 432.00M | -0.41% | 764,522 | 212.07M |
| 231 | IMMP | Immutep Limited | 428.84M | -1.51% | 38,658 | 3.31M |
| 232 | LXRX | Lexicon Pharmaceuticals, Inc. | 428.81M | - | 725,654 | 70.86M |
| 233 | DMAC | DiaMedica Therapeutics Inc. | 428.08M | -1.56% | 64,506 | - |
| 234 | FDMT | 4D Molecular Therapeutics, Inc. | 427.94M | 2.60% | 353,007 | 120.00K |
| 235 | FBRX | Forte Biosciences, Inc. | 426.17M | -1.16% | 190,251 | - |
| 236 | NBP | NovaBridge Biosciences | 421.97M | -3.43% | 818,246 | - |
| 237 | MNPR | Monopar Therapeutics Inc. | 421.67M | -0.47% | 283,737 | - |
| 238 | PRTC | PureTech Health plc | 416.82M | 0.12% | 458 | 6.39M |
| 239 | LCTX | Lineage Cell Therapeutics, Inc. | 414.62M | -2.78% | 511,060 | 10.82M |
| 240 | SLDB | Solid Biosciences Inc. | 404.74M | -2.17% | 325,663 | - |
| 241 | RCKT | Rocket Pharmaceuticals, Inc. | 402.05M | -4.25% | 1,043,734 | - |
| 242 | BNTC | Benitec Biopharma Inc. | 399.74M | -3.08% | 52,511 | - |
| 243 | NMRA | Neumora Therapeutics, Inc. | 399.36M | 0.86% | 1,613,960 | - |
| 244 | ALLO | Allogene Therapeutics, Inc. | 395.53M | 18.12% | 9,658,666 | 22.00K |
| 245 | AVXL | Anavex Life Sciences Corp. | 381.52M | - | 831,870 | - |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 378.10M | -2.53% | 123,950 | 65.32M |
| 247 | HELP | Cybin Inc. | 375.77M | 2.17% | 419,971 | - |
| 248 | XOMA | XOMA Royalty Corporation | 369.39M | -0.30% | 785,780 | 47.11M |
| 249 | TECX | Tectonic Therapeutic, Inc. | 363.10M | -9.60% | 192,693 | - |
| 250 | TRDA | Entrada Therapeutics, Inc. | 362.56M | -3.90% | 39,780 | 61.52M |
| 251 | GLSI | Greenwich LifeSciences, Inc. | 359.04M | 15.64% | 390,796 | - |
| 252 | XFOR | X4 Pharmaceuticals, Inc. | 349.75M | -0.99% | 860,654 | 33.98M |
| 253 | ACIU | AC Immune SA | 339.37M | -0.29% | 220,412 | 5.48M |
| 254 | CTNM | Contineum Therapeutics, Inc. | 338.99M | 1.20% | 173,436 | - |
| 255 | CLLS | Cellectis S.A. | 332.51M | -1.79% | 27,568 | 82.55M |
| 256 | ZURA | Zura Bio Limited | 327.07M | -4.37% | 180,408 | - |
| 257 | AURA | Aura Biosciences, Inc. | 319.42M | -2.52% | 94,869 | - |
| 258 | RLMD | Relmada Therapeutics, Inc. | 313.50M | -3.50% | 188,867 | - |
| 259 | CAMP | Camp4 Therapeutics Corporation | 313.36M | -2.58% | 85,798 | 3.80M |
| 260 | CADL | Candel Therapeutics, Inc. | 310.72M | 1.98% | 447,153 | - |
| 261 | AARD | Aardvark Therapeutics, Inc. | 310.05M | -1.86% | 60,335 | - |
| 262 | TARA | Protara Therapeutics, Inc. | 309.20M | 2.85% | 485,480 | - |
| 263 | PBYI | Puma Biotechnology, Inc. | 308.39M | -1.29% | 217,107 | 212.00M |
| 264 | IMRX | Immuneering Corporation | 308.00M | 0.85% | 3,811,816 | - |
| 265 | AVTX | Avalo Therapeutics, Inc. | 305.74M | -1.46% | 86,232 | 192.00K |
| 266 | STTK | Shattuck Labs, Inc. | 300.58M | 2.37% | 1,409,057 | 1.00M |
| 267 | FHTX | Foghorn Therapeutics Inc. | 294.63M | -0.38% | 98,368 | 24.52M |
| 268 | MENS | Jyong Biotech Ltd. | 292.99M | -4.75% | 162,706 | - |
| 269 | PALI | Palisade Bio, Inc. | 289.81M | 2.37% | 3,550,169 | - |
| 270 | ACRS | Aclaris Therapeutics, Inc. | 288.20M | -0.75% | 298,665 | 15.74M |
| 271 | ACHV | Achieve Life Sciences, Inc. | 286.40M | -1.65% | 654,834 | - |
| 272 | LRMR | Larimar Therapeutics, Inc. | 285.02M | -0.89% | 515,354 | - |
| 273 | ABEO | Abeona Therapeutics Inc. | 279.63M | 1.38% | 1,023,826 | 400.00K |
| 274 | NGNE | Neurogene Inc. | 278.82M | -3.64% | 60,550 | 925.00K |
| 275 | GUTS | Fractyl Health, Inc. | 278.20M | -3.33% | 2,065,008 | 3.00K |
| 276 | OABI | OmniAb, Inc. | 274.95M | 1.06% | 138,038 | 21.09M |
| 277 | OBIO | Orchestra BioMed Holdings, Inc. | 272.44M | -0.31% | 234,556 | 2.82M |
| 278 | FENC | Fennec Pharmaceuticals Inc. | 269.81M | 4.22% | 99,706 | 38.79M |
| 279 | AVIR | Atea Pharmaceuticals, Inc. | 269.15M | -4.57% | 205,106 | - |
| 280 | HRTX | Heron Therapeutics, Inc. | 261.29M | 12.20% | 6,037,240 | 155.10M |
| 281 | NAUT | Nautilus Biotechnology, Inc. | 260.82M | -6.98% | 273,234 | - |
| 282 | SLN | Silence Therapeutics plc | 260.26M | -5.00% | 165,642 | 25.83M |
| 283 | IMMX | Immix Biopharma, Inc. | 255.05M | -4.91% | 873,810 | - |
| 284 | ARMP | Armata Pharmaceuticals, Inc. | 253.21M | -11.85% | 42,801 | 5.05M |
| 285 | RZLT | Rezolute, Inc. | 242.95M | 10.55% | 4,262,984 | - |
| 286 | ALDX | Aldeyra Therapeutics, Inc. | 242.76M | -3.47% | 370,948 | - |
| 287 | MDWD | MediWound Ltd. | 240.91M | -2.64% | 49,701 | 20.93M |
| 288 | CLYM | Climb Bio, Inc. | 238.24M | 8.95% | 1,024,143 | - |
| 289 | IKT | Inhibikase Therapeutics, Inc. | 234.58M | 2.69% | 419,079 | 1.00 |
| 290 | ZNTL | Zentalis Pharmaceuticals, Inc. | 231.16M | 25.70% | 8,225,716 | 26.87M |
| 291 | HUMA | Humacyte, Inc. | 226.77M | 0.43% | 2,039,028 | 1.57M |
| 292 | VYGR | Voyager Therapeutics, Inc. | 220.18M | -2.46% | 186,890 | 31.32M |
| 293 | PRLD | Prelude Therapeutics Incorporated | 219.18M | -3.62% | 501,307 | 10.50M |
| 294 | OVID | Ovid Therapeutics Inc. | 216.76M | -3.76% | 664,934 | 6.61M |
| 295 | ENLV | Enlivex Therapeutics Ltd. | 215.85M | 8.52% | 349,134 | - |
| 296 | NVCT | Nuvectis Pharma, Inc. | 213.63M | -5.76% | 55,718 | - |
| 297 | CCCC | C4 Therapeutics, Inc. | 208.37M | -1.83% | 672,828 | 30.11M |
| 298 | CRDF | Cardiff Oncology, Inc. | 207.47M | -2.84% | 748,368 | 501.00K |
| 299 | CBIO | Crescent Biopharma, Inc. | 207.23M | -3.37% | 49,650 | - |
| 300 | MIST | Milestone Pharmaceuticals Inc. | 206.21M | -7.31% | 5,469,650 | - |
| 301 | CHRS | Coherus Oncology, Inc. | 204.88M | 10.78% | 3,423,819 | 277.73M |
| 302 | SGMT | Sagimet Biosciences Inc. | 203.91M | 12.57% | 1,781,401 | - |
| 303 | RNAC | Cartesian Therapeutics, Inc. | 203.09M | -3.82% | 123,877 | 1.09M |
| 304 | EDIT | Editas Medicine, Inc. | 202.56M | -3.04% | 684,108 | 46.38M |
| 305 | CABA | Cabaletta Bio, Inc. | 201.19M | -3.69% | 808,397 | - |
| 306 | GALT | Galectin Therapeutics Inc. | 199.22M | -3.44% | 554,205 | - |
| 307 | ALEC | Alector, Inc. | 198.11M | 2.54% | 856,580 | 69.05M |
| 308 | TNXP | Tonix Pharmaceuticals Holding Corp. | 192.81M | 2.57% | 128,764 | 10.30M |
| 309 | ARCT | Arcturus Therapeutics Holdings Inc. | 191.80M | -0.30% | 218,113 | 97.60M |
| 310 | NERV | Minerva Neurosciences, Inc. | 191.27M | -5.96% | 38,683 | - |
| 311 | KLRS | Kalaris Therapeutics, Inc. | 190.89M | 23.57% | 199,546 | - |
| 312 | NTHI | NeOnc Technologies Holdings, Inc. | 190.48M | -0.50% | 57,469 | 59.99K |
| 313 | PRQR | ProQR Therapeutics N.V. | 188.57M | -14.76% | 937,699 | 18.86M |
| 314 | CGEN | Compugen Ltd. | 173.98M | 13.41% | 959,589 | 6.90M |
| 315 | SABS | SAB Biotherapeutics, Inc. | 172.81M | -5.96% | 348,090 | 114.70K |
| 316 | TLSA | Tiziana Life Sciences Ltd | 170.51M | -3.04% | 237,947 | - |
| 317 | RANI | Rani Therapeutics Holdings, Inc. | 167.70M | -0.72% | 653,315 | 1.20M |
| 318 | PLX | Protalix BioTherapeutics, Inc. | 167.28M | 4.00% | 1,305,833 | 61.84M |
| 319 | TNYA | Tenaya Therapeutics, Inc. | 164.93M | -1.32% | 2,517,742 | - |
| 320 | IPSC | Century Therapeutics, Inc. | 164.15M | 6.21% | 1,756,913 | 113.34M |
| 321 | IPHA | Innate Pharma S.A. | 163.41M | 4.02% | 9,237 | 14.84M |
| 322 | SLGL | Sol-Gel Technologies Ltd. | 162.97M | 5.06% | 11,897 | 18.97M |
| 323 | KPTI | Karyopharm Therapeutics Inc. | 159.85M | 6.85% | 703,007 | 142.53M |
| 324 | BDTX | Black Diamond Therapeutics, Inc. | 158.96M | 0.36% | 867,168 | 70.00M |
| 325 | SRZN | Surrozen, Inc. | 158.14M | -3.20% | 55,382 | 3.60M |
| 326 | CRBU | Caribou Biosciences, Inc. | 155.59M | -1.50% | 494,370 | 9.30M |
| 327 | MOLN | Molecular Partners AG | 154.88M | -0.71% | 2,249 | 856.30K |
| 328 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 154.34M | -0.36% | 109,658 | - |
| 329 | QNCX | Quince Therapeutics, Inc. | 149.50M | 0.19% | 302,800 | - |
| 330 | CDXS | Codexis, Inc. | 149.04M | -1.79% | 269,839 | 52.93M |
| 331 | SGMO | Sangamo Therapeutics, Inc. | 146.78M | -3.11% | 1,785,047 | 32.88M |
| 332 | NKTX | Nkarta, Inc. | 146.60M | -2.18% | 563,101 | - |
| 333 | CNTX | Context Therapeutics Inc. | 143.79M | -2.19% | 563,251 | - |
| 334 | SPRO | Spero Therapeutics, Inc. | 142.54M | -1.56% | 97,073 | 40.55M |
| 335 | ACOG | Alpha Cognition Inc. | 141.98M | -0.46% | 47,782 | 7.43M |
| 336 | ACTU | Actuate Therapeutics, Inc. | 141.55M | -3.03% | 51,981 | - |
| 337 | MCRB | Seres Therapeutics, Inc. | 141.40M | 1.17% | 16,423 | 351.00K |
| 338 | ELTX | Elicio Therapeutics, Inc. | 141.20M | -1.94% | 130,825 | - |
| 339 | VXRT | Vaxart, Inc. | 139.38M | 21.03% | 3,262,865 | 148.20M |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 137.52M | -0.72% | 192,796 | 2.00M |
| 341 | FBIO | Fortress Biotech, Inc. | 137.19M | 0.91% | 713,874 | 62.30M |
| 342 | TTRX | Turn Therapeutics Inc. | 136.92M | - | 9,554 | - |
| 343 | ELDN | Eledon Pharmaceuticals, Inc. | 136.88M | -0.29% | 228,737 | - |
| 344 | IRD | Opus Genetics, Inc. | 134.14M | -2.75% | 494,938 | 14.63M |
| 345 | AGEN | Agenus Inc. | 132.63M | 4.00% | 578,000 | 106.83M |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 130.67M | -0.65% | 311,053 | - |
| 347 | HYFT | MindWalk Holdings Corp. | 129.80M | - | 457,952 | 19.02M |
| 348 | CGTX | Cognition Therapeutics, Inc. | 125.79M | -0.35% | 318,440 | - |
| 349 | VRCA | Verrica Pharmaceuticals Inc. | 125.52M | -2.12% | 92,140 | 30.83M |
| 350 | WHWK | Whitehawk Therapeutics, Inc. | 123.95M | -2.95% | 48,778 | 14.38M |
| 351 | FATE | Fate Therapeutics, Inc. | 121.12M | -0.94% | 872,558 | 7.14M |
| 352 | CNTB | Connect Biopharma Holdings Limited | 121.09M | -2.87% | 26,800 | 762.00K |
| 353 | ARTV | Artiva Biotherapeutics, Inc. | 115.61M | 2.84% | 188,445 | 251.00K |
| 354 | MGNX | MacroGenics, Inc. | 114.50M | 1.12% | 883,969 | 127.63M |
| 355 | ANIX | Anixa Biosciences, Inc. | 111.59M | -0.88% | 353,515 | - |
| 356 | STRO | Sutro Biopharma, Inc. | 111.05M | 10.94% | 114,410 | 105.65M |
| 357 | RPTX | Repare Therapeutics Inc. | 109.50M | 0.40% | 617,593 | 11.87M |
| 358 | PYXS | Pyxis Oncology, Inc. | 107.09M | 18.62% | 2,047,776 | 2.82M |
| 359 | INO | Inovio Pharmaceuticals, Inc. | 106.83M | -3.42% | 1,375,889 | 182.34K |
| 360 | SEER | Seer, Inc. | 106.32M | 1.07% | 104,106 | 16.38M |
| 361 | ABOS | Acumen Pharmaceuticals, Inc. | 105.40M | -6.45% | 184,952 | - |
| 362 | GNLX | Genelux Corporation | 104.58M | 2.21% | 375,296 | 8.00K |
| 363 | ONCY | Oncolytics Biotech Inc. | 103.84M | -2.68% | 463,813 | - |
| 364 | OKYO | OKYO Pharma Limited | 103.43M | 18.53% | 660,220 | - |
| 365 | CBUS | Cibus, Inc. | 103.14M | -7.32% | 291,103 | 3.79M |
| 366 | SAVA | Cassava Sciences, Inc. | 101.69M | -1.64% | 407,223 | - |
| 367 | THAR | Tharimmune, Inc. | 101.68M | -4.12% | 254,532 | - |
| 368 | ATRA | Atara Biotherapeutics, Inc. | 101.02M | -19.67% | 657,904 | 151.93M |
| 369 | COYA | Coya Therapeutics, Inc. | 100.65M | -6.05% | 486,869 | 3.99M |
| 370 | ANVS | Annovis Bio, Inc. | 99.92M | -3.83% | 260,264 | - |
| 371 | BMEA | Biomea Fusion, Inc. | 99.69M | 5.22% | 1,113,306 | - |
| 372 | VANI | Vivani Medical, Inc. | 96.30M | 0.76% | 62,910 | - |
| 373 | DTIL | Precision BioSciences, Inc. | 94.12M | -2.98% | 205,973 | 698.00K |
| 374 | CSBR | Champions Oncology, Inc. | 93.87M | -0.46% | 2,402 | 58.42M |
| 375 | ETHZ | ETHZilla Corporation | 90.69M | -2.25% | 359,594 | 4.11M |
| 376 | GANX | Gain Therapeutics, Inc. | 89.62M | -4.51% | 741,735 | - |
| 377 | KRRO | Korro Bio, Inc. | 89.18M | 3.50% | 175,889 | 7.37M |
| 378 | PTHS | Pelthos Therapeutics Inc. | 84.11M | -2.89% | 18,220 | 7.41M |
| 379 | SPRB | Spruce Biosciences, Inc. | 84.10M | 6.61% | 23,846 | 697.00K |
| 380 | DWTX | Dogwood Therapeutics, Inc. | 83.24M | -11.11% | 91,512 | - |
| 381 | ATOS | Atossa Therapeutics, Inc. | 82.81M | -1.82% | 781,448 | - |
| 382 | ADAG | Adagene Inc. | 82.27M | 5.79% | 30,583 | 103.20K |
| 383 | CALC | CalciMedica, Inc. | 82.13M | 6.94% | 70,674 | - |
| 384 | EXOZ | eXoZymes, Inc. | 81.78M | 0.72% | 2,870 | -700.00 |
| 385 | ACET | Adicet Bio, Inc. | 81.46M | -0.37% | 112,645 | - |
| 386 | COEP | Coeptis Therapeutics Holdings, Inc. | 80.83M | -3.20% | 25,813 | 501.00K |
| 387 | PLRX | Pliant Therapeutics, Inc. | 80.81M | 0.38% | 1,277,835 | - |
| 388 | IMUX | Immunic, Inc. | 79.46M | -0.32% | 1,423,261 | - |
| 389 | PSTV | Plus Therapeutics, Inc. | 77.95M | -3.06% | 2,720,434 | 5.26M |
| 390 | XBIT | XBiotech Inc. | 77.74M | -3.77% | 33,998 | - |
| 391 | PYPD | PolyPid Ltd. | 77.10M | -0.32% | 31,332 | - |
| 392 | KZIA | Kazia Therapeutics Limited | 75.73M | 2.51% | 164,586 | 1.20M |
| 393 | IMA | ImageneBio, Inc. | 75.20M | 3.07% | 4,798 | 800.00K |
| 394 | MNOV | MediciNova, Inc. | 75.19M | 7.75% | 58,898 | 257.92K |
| 395 | TVGN | Tevogen Bio Holdings Inc. | 74.99M | -3.23% | 1,926,543 | - |
| 396 | ENTX | Entera Bio Ltd. | 74.75M | -6.32% | 187,701 | 124.00K |
| 397 | MREO | Mereo BioPharma Group plc | 74.28M | 21.44% | 25,378,460 | 500.00K |
| 398 | ALXO | ALX Oncology Holdings Inc. | 73.74M | 9.68% | 247,738 | - |
| 399 | IFRX | InflaRx N.V. | 73.17M | -0.92% | 399,022 | 73.73K |
| 400 | CRVO | CervoMed Inc. | 71.34M | -2.03% | 52,156 | 6.16M |
| 401 | EQ | Equillium, Inc. | 71.25M | 3.54% | 241,517 | 4.39M |
| 402 | TCRX | TScan Therapeutics, Inc. | 70.37M | 5.08% | 683,833 | 8.42M |
| 403 | ATYR | aTyr Pharma, Inc. | 69.83M | -1.72% | 1,070,003 | 190.00K |
| 404 | MGX | Metagenomi, Inc. | 67.58M | 1.69% | 196,186 | 30.91M |
| 405 | NRXP | NRx Pharmaceuticals, Inc. | 65.72M | -4.72% | 363,317 | 242.00K |
| 406 | BYSI | BeyondSpring Inc. | 65.38M | - | 19,736 | 1.88M |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 63.32M | - | 156,346 | - |
| 408 | PASG | Passage Bio, Inc. | 62.50M | 7.27% | 142,221 | - |
| 409 | MAIA | MAIA Biotechnology, Inc. | 60.84M | -4.22% | 318,270 | - |
| 410 | ANL | Adlai Nortye Ltd. | 60.15M | 10.88% | 84,629 | -1.35M |
| 411 | ICCC | ImmuCell Corporation | 59.25M | -0.30% | 17,027 | 27.77M |
| 412 | RADX | Radiopharm Theranostics Limited | 59.17M | 5.89% | 116,379 | 8.20M |
| 413 | IBIO | iBio, Inc. | 59.03M | 11.70% | 11,420,282 | 500.00K |
| 414 | GRCE | Grace Therapeutics, Inc. | 58.96M | 0.26% | 127,883 | - |
| 415 | ACRV | Acrivon Therapeutics, Inc. | 58.69M | -3.63% | 3,595,920 | - |
| 416 | INKT | MiNK Therapeutics, Inc. | 58.21M | - | 9,228 | - |
| 417 | ATHE | Alterity Therapeutics Limited | 58.10M | 5.11% | 4,523 | 3.57M |
| 418 | PDSB | PDS Biotechnology Corporation | 58.00M | 6.71% | 2,571,668 | - |
| 419 | ALGS | Aligos Therapeutics, Inc. | 57.60M | -9.39% | 68,241 | 2.65M |
| 420 | OSTX | OS Therapies Incorporated | 55.64M | 2.60% | 555,123 | - |
| 421 | LITS | Lite Strategy, Inc. | 53.32M | -2.68% | 219,692 | - |
| 422 | NTRB | Nutriband Inc. | 53.24M | -0.90% | 12,760 | 2.28M |
| 423 | IBO | Impact BioMedical Inc. | 52.17M | -1.45% | 34,707 | 25.00K |
| 424 | NRXS | NeurAxis, Inc. | 51.69M | 4.79% | 168,784 | 3.36M |
| 425 | ABVC | ABVC BioPharma, Inc. | 51.62M | -2.67% | 57,914 | 797.92K |
| 426 | APLM | Apollomics, Inc. | 47.97M | -0.75% | 21,748 | 6.93M |
| 427 | TIL | Instil Bio, Inc. | 47.68M | -4.87% | 185,789 | - |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 47.27M | -3.18% | 182,790 | - |
| 429 | PTN | Palatin Technologies, Inc. | 47.18M | -6.85% | 24,588 | 8.85M |
| 430 | CVM | CEL-SCI Corporation | 46.67M | -5.29% | 34,853 | - |
| 431 | KZR | Kezar Life Sciences, Inc. | 45.77M | -3.85% | 86,552 | - |
| 432 | ANEB | Anebulo Pharmaceuticals, Inc. | 45.71M | -6.51% | 22,673 | - |
| 433 | HURA | TuHURA Biosciences, Inc. | 45.60M | -0.48% | 257,177 | - |
| 434 | NXTC | NextCure, Inc. | 45.57M | -4.34% | 36,185 | - |
| 435 | QTTB | Q32 Bio Inc. | 43.99M | -0.14% | 126,620 | - |
| 436 | ATNM | Actinium Pharmaceuticals, Inc. | 43.99M | -1.40% | 43,494 | 90.00K |
| 437 | ESLA | Estrella Immunopharma, Inc. | 43.81M | -18.31% | 120,959 | - |
| 438 | JSPR | Jasper Therapeutics, Inc. | 43.52M | -6.33% | 1,684,134 | - |
| 439 | LPCN | Lipocine Inc. | 43.03M | 2.92% | 42,366 | 4.32M |
| 440 | OKUR | OnKure Therapeutics, Inc. | 42.68M | 10.14% | 225,773 | - |
| 441 | EVAX | Evaxion A/S | 42.18M | -1.02% | 15,635 | 7.65M |
| 442 | TVRD | Tvardi Therapeutics, Inc. | 41.75M | 5.20% | 234,366 | - |
| 443 | RNXT | RenovoRx, Inc. | 41.05M | -2.61% | 752,389 | 928.00K |
| 444 | IOBT | IO Biotech, Inc. | 41.00M | 3.15% | 471,480 | - |
| 445 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 40.93M | -4.29% | 3,347,375 | - |
| 446 | INMB | INmune Bio, Inc. | 39.74M | -2.29% | 235,181 | 50.00K |
| 447 | LTRN | Lantern Pharma Inc. | 39.15M | 3.24% | 47,631 | - |
| 448 | OTLK | Outlook Therapeutics, Inc. | 39.13M | 0.98% | 3,177,570 | 1.41M |
| 449 | VERU | Veru Inc. | 37.88M | 2.16% | 80,807 | 16.89M |
| 450 | XCUR | Exicure, Inc. | 37.67M | 0.51% | 18,043 | 500.00K |
| 451 | GBIO | Generation Bio Co. | 36.93M | -0.54% | 52,288 | 15.27M |
| 452 | XLO | Xilio Therapeutics, Inc. | 36.62M | -3.58% | 481,210 | 31.80M |
| 453 | JUNS | Jupiter Neurosciences, Inc. | 36.49M | 2.91% | 75,574 | - |
| 454 | ANTX | AN2 Therapeutics, Inc. | 36.44M | 0.76% | 49,865 | - |
| 455 | CELU | Celularity Inc. | 36.17M | 0.80% | 16,447 | 40.58M |
| 456 | DYAI | Dyadic International, Inc. | 34.02M | -2.91% | 28,427 | 3.34M |
| 457 | CING | Cingulate Inc. | 33.73M | -7.58% | 322,658 | - |
| 458 | MRKR | Marker Therapeutics, Inc. | 33.68M | -2.42% | 498,058 | 4.69M |
| 459 | GNTA | Genenta Science S.p.A. | 32.81M | -2.78% | 45,972 | - |
| 460 | CUE | Cue Biopharma, Inc. | 32.27M | -9.99% | 814,494 | 7.10M |
| 461 | GLTO | Galecto, Inc. | 31.90M | -1.82% | 9,854 | - |
| 462 | LIXT | Lixte Biotechnology Holdings, Inc. | 31.89M | -2.40% | 51,385 | - |
| 463 | NRSN | NeuroSense Therapeutics Ltd. | 31.75M | 13.96% | 351,476 | - |
| 464 | SKYE | Skye Bioscience, Inc. | 31.42M | -6.67% | 265,742 | - |
| 465 | RNTX | Rein Therapeutics Inc. | 30.36M | -5.33% | 95,732 | - |
| 466 | RLYB | Rallybio Corporation | 30.05M | -3.62% | 36,377 | 674.00K |
| 467 | BRNS | Barinthus Biotherapeutics plc | 30.02M | -3.00% | 15,084 | 14.97M |
| 468 | BOLD | Boundless Bio, Inc. | 29.80M | 1.64% | 48,104 | - |
| 469 | HOWL | Werewolf Therapeutics, Inc. | 29.26M | -4.38% | 289,099 | 1.14M |
| 470 | QNTM | Quantum BioPharma Ltd. | 29.20M | -2.75% | 23,022 | - |
| 471 | SNTI | Senti Biosciences, Inc. | 28.92M | 1.85% | 222,765 | - |
| 472 | DARE | Daré Bioscience, Inc. | 28.72M | -2.89% | 21,839 | -57.13K |
| 473 | IGC | IGC Pharma, Inc. | 28.15M | -0.62% | 153,740 | 1.11M |
| 474 | PLUR | Pluri Inc. | 28.11M | 1.22% | 1,457 | 1.33M |
| 475 | ATHA | Athira Pharma, Inc. | 27.09M | -4.45% | 46,615 | - |
| 476 | HYPD | Hyperion DeFi, Inc. | 27.05M | -4.06% | 159,125 | 345.32K |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 26.39M | -5.07% | 1,466,503 | 721.00K |
| 478 | SER | Serina Therapeutics, Inc. | 26.23M | -6.11% | 50,091 | 116.00K |
| 479 | KLTO | Klotho Neurosciences, Inc. | 25.50M | 2.66% | 262,881 | - |
| 480 | PLRZ | Polyrizon Ltd. | 25.26M | -4.55% | 32,121 | - |
| 481 | INTS | Intensity Therapeutics, Inc. | 25.19M | -3.41% | 567,919 | - |
| 482 | NNVC | NanoViricides, Inc. | 24.80M | -4.96% | 247,282 | - |
| 483 | FBLG | FibroBiologics, Inc. | 23.42M | 6.70% | 615,308 | - |
| 484 | NEUP | Neuphoria Therapeutics Inc. | 22.48M | 2.70% | 49,345 | 15.65M |
| 485 | BCAB | BioAtla, Inc. | 21.60M | -8.66% | 1,360,443 | 11.00M |
| 486 | CASI | CASI Pharmaceuticals, Inc. | 21.58M | -1.41% | 113,823 | 26.85M |
| 487 | KTTA | Pasithea Therapeutics Corp. | 21.01M | -1.19% | 84,199 | - |
| 488 | LNAI | Lunai Bioworks Inc. | 20.85M | -2.22% | 77,676 | - |
| 489 | LIMN | Liminatus Pharma, Inc. | 20.57M | -7.33% | 138,809 | - |
| 490 | ALLR | Allarity Therapeutics, Inc. | 20.37M | -1.43% | 60,202 | - |
| 491 | CVKD | Cadrenal Therapeutics, Inc. | 19.45M | 5.58% | 63,987 | - |
| 492 | CLGN | CollPlant Biotechnologies Ltd. | 19.28M | 4.82% | 11,747 | 2.48M |
| 493 | VYNE | VYNE Therapeutics Inc. | 18.74M | -1.07% | 298,327 | 524.00K |
| 494 | KAPA | Kairos Pharma, Ltd. | 18.45M | -8.66% | 121,625 | - |
| 495 | PMN | ProMIS Neurosciences, Inc. | 18.21M | -0.24% | 3,457 | - |
| 496 | OSRH | OSR Holdings, Inc. | 17.89M | 12.06% | 578,223 | -90.52K |
| 497 | CTXR | Citius Pharmaceuticals, Inc. | 17.86M | -4.44% | 211,171 | - |
| 498 | MTVA | MetaVia Inc. | 17.72M | -3.97% | 5,777 | - |
| 499 | ITRM | Iterum Therapeutics plc | 17.68M | -2.45% | 245,285 | 390.00K |
| 500 | LSTA | Lisata Therapeutics, Inc. | 17.59M | -3.20% | 28,994 | 1.07M |
| 501 | LEXX | Lexaria Bioscience Corp. | 17.15M | -0.86% | 179,213 | 705.92K |
| 502 | HOTH | Hoth Therapeutics, Inc. | 16.91M | -0.91% | 64,242 | - |
| 503 | COCP | Cocrystal Pharma, Inc. | 16.06M | 5.91% | 134,002 | - |
| 504 | GRDX | GridAI Technologies Corp. | 15.35M | 1.00% | 46,762 | - |
| 505 | APLT | Applied Therapeutics, Inc. | 15.06M | -1.40% | 3,233,769 | 1.00M |
| 506 | GDTC | CytoMed Therapeutics Limited | 15.00M | -0.76% | 1,906 | 573.19K |
| 507 | BCDA | BioCardia, Inc. | 14.65M | 4.55% | 85,243 | 3.00K |
| 508 | NCNA | NuCana plc | 14.57M | -2.78% | 40,769 | - |
| 509 | SNSE | Sensei Biotherapeutics, Inc. | 14.56M | 4.41% | 22,633 | - |
| 510 | KALA | KALA BIO, Inc. | 14.53M | -3.68% | 997,201 | - |
| 511 | TPST | Tempest Therapeutics, Inc. | 14.39M | 1.39% | 32,656 | - |
| 512 | SYBX | Synlogic, Inc. | 13.80M | -3.28% | 22,404 | 8.00K |
| 513 | SNGX | Soligenix, Inc. | 13.77M | -5.21% | 98,157 | 2.34K |
| 514 | BCTX | BriaCell Therapeutics Corp. | 13.63M | -1.79% | 37,784 | - |
| 515 | LGVN | Longeveron Inc. | 13.21M | -1.58% | 211,671 | 1.44M |
| 516 | AKTX | Akari Therapeutics, Plc | 13.07M | 1.06% | 219,404 | - |
| 517 | CLRB | Cellectar Biosciences, Inc. | 13.06M | -6.95% | 67,089 | - |
| 518 | IMNN | Imunon, Inc. | 12.72M | -3.11% | 35,674 | - |
| 519 | AEON | AEON Biopharma, Inc. | 12.55M | -2.75% | 62,805 | - |
| 520 | EDSA | Edesa Biotech, Inc. | 12.50M | -0.66% | 11,459 | - |
| 521 | PHIO | Phio Pharmaceuticals Corp. | 12.43M | -2.94% | 97,067 | - |
| 522 | MBRX | Moleculin Biotech, Inc. | 12.38M | -2.19% | 81,780 | - |
| 523 | BLRX | BioLineRx Ltd. | 12.33M | -2.35% | 5,327 | 12.74M |
| 524 | CMMB | Chemomab Therapeutics Ltd. | 11.33M | 2.22% | 42,417 | - |
| 525 | INAB | IN8bio, Inc. | 11.31M | 1.72% | 176,575 | - |
| 526 | ABP | Abpro Holdings, Inc. | 11.16M | 1.23% | 7,070 | 183.00K |
| 527 | BOLT | Bolt Biotherapeutics, Inc. | 11.06M | -0.86% | 5,776 | 5.20M |
| 528 | TRAW | Traws Pharma, Inc. | 10.95M | -2.84% | 21,277 | 2.85M |
| 529 | BRTX | BioRestorative Therapies, Inc. | 10.74M | 0.83% | 8,503 | 383.40K |
| 530 | ASBP | Aspire Biopharma Holdings, Inc. | 10.69M | -3.68% | 20,007,038 | 1.94K |
| 531 | CRIS | Curis, Inc. | 10.67M | -2.92% | 497,629 | 11.65M |
| 532 | ERNA | Ernexa Therapeutics Inc. | 10.36M | -5.04% | 35,312 | 1,000.00 |
| 533 | QNRX | Quoin Pharmaceuticals, Ltd. | 10.24M | -7.15% | 26,761 | - |
| 534 | NCEL | NewcelX Ltd. | 9.94M | -1.36% | 37,577 | - |
| 535 | EVGN | Evogene Ltd. | 9.90M | 0.45% | 20,782 | 8.02M |
| 536 | BIVI | BioVie Inc. | 9.72M | -0.77% | 25,010 | - |
| 537 | ALZN | Alzamend Neuro, Inc. | 9.09M | 2.14% | 65,264 | - |
| 538 | PMCB | PharmaCyte Biotech, Inc. | 9.02M | -3.34% | 149,315 | - |
| 539 | APVO | Aptevo Therapeutics Inc. | 8.67M | 0.71% | 6,036,139 | - |
| 540 | APM | Aptorum Group Limited | 8.63M | -1.85% | 53,526 | - |
| 541 | PULM | Pulmatrix, Inc. | 8.62M | 0.43% | 9,238 | 3.00K |
| 542 | MBIO | Mustang Bio, Inc. | 8.47M | 1.75% | 44,352 | - |
| 543 | CLDI | Calidi Biotherapeutics, Inc. | 8.42M | -0.86% | 26,829 | - |
| 544 | ICU | SeaStar Medical Holding Corporation | 8.22M | -5.39% | 73,807 | 881.00K |
| 545 | ADXN | Addex Therapeutics Ltd | 8.08M | -1.02% | 776 | 198.82K |
| 546 | KPRX | Kiora Pharmaceuticals, Inc. | 8.00M | -0.23% | 90,101 | 20.00K |
| 547 | IMRN | Immuron Limited | 7.84M | 5.12% | 10,851 | 4.78M |
| 548 | PCSA | Processa Pharmaceuticals, Inc. | 7.82M | -0.29% | 97,254 | - |
| 549 | CELZ | Creative Medical Technology Holdings, Inc. | 7.79M | -8.98% | 119,011 | 6.00K |
| 550 | RNAZ | TransCode Therapeutics, Inc. | 7.45M | 2.52% | 17,590 | - |
| 551 | CYCN | Cyclerion Therapeutics, Inc. | 7.35M | - | 331,790 | 2.86M |
| 552 | TOVX | Theriva Biologics, Inc. | 7.30M | -1.34% | 837,594 | - |
| 553 | GOVX | GeoVax Labs, Inc. | 7.15M | -9.90% | 4,156,196 | 3.35M |
| 554 | GTBP | GT Biopharma, Inc. | 7.12M | -1.54% | 1,434,225 | - |
| 555 | BGMS | Bio Green Med Solution, Inc. | 7.03M | 5.51% | 16,074 | 81.00K |
| 556 | PPBT | Purple Biotech Ltd | 7.02M | -4.14% | 52,456 | - |
| 557 | ACXP | Acurx Pharmaceuticals, Inc. | 7.00M | 2.05% | 13,346 | - |
| 558 | TCRT | Alaunos Therapeutics, Inc. | 6.99M | -11.58% | 46,520 | 6.00K |
| 559 | LYRA | Lyra Therapeutics, Inc. | 6.82M | 1.05% | 4,362 | 600.00K |
| 560 | SLXN | Silexion Therapeutics Corp | 6.72M | 2.28% | 20,392 | - |
| 561 | APRE | Aprea Therapeutics, Inc. | 6.64M | 1.05% | 71,880 | 488.24K |
| 562 | XTLB | XTL Biopharmaceuticals Ltd. | 6.55M | -5.93% | 31,740 | 968.00K |
| 563 | ADIL | Adial Pharmaceuticals, Inc. | 6.51M | 4.58% | 172,688 | - |
| 564 | PPCB | Propanc Biopharma, Inc. | 6.15M | -4.14% | 72,112 | - |
| 565 | CANF | Can-Fite BioPharma Ltd. | 5.67M | -3.42% | 22,761 | 560.00K |
| 566 | INDP | Indaptus Therapeutics, Inc. | 5.47M | 4.17% | 116,920 | - |
| 567 | GNPX | Genprex, Inc. | 5.36M | 15.50% | 2,268,096 | - |
| 568 | REVB | Revelation Biosciences, Inc. | 5.33M | -0.02% | 47,077 | - |
| 569 | SILO | Silo Pharma, Inc. | 5.23M | 0.93% | 38,288 | 72.10K |
| 570 | DCOY | Decoy Therapeutics Inc. | 5.13M | 4.40% | 207,876 | - |
| 571 | VIVS | VivoSim Labs, Inc. | 5.09M | -6.25% | 46,855 | 140.00K |
| 572 | XBIO | Xenetic Biosciences, Inc. | 4.99M | -0.23% | 5,776 | 2.86M |
| 573 | JAGX | Jaguar Health, Inc. | 4.90M | - | 122,447 | 11.79M |
| 574 | SPRC | SciSparc Ltd. | 4.78M | -3.31% | 80,324 | 1.31M |
| 575 | MTNB | Matinas BioPharma Holdings, Inc. | 4.65M | -0.07% | 12,522 | - |
| 576 | GLMD | Galmed Pharmaceuticals Ltd. | 4.55M | -2.33% | 40,413 | - |
| 577 | ENVB | Enveric Biosciences, Inc. | 4.14M | -0.74% | 12,544 | - |
| 578 | XRTX | XORTX Therapeutics Inc. | 4.13M | -0.42% | 6,350 | - |
| 579 | CNSP | CNS Pharmaceuticals, Inc. | 3.72M | 0.84% | 15,160 | - |
| 580 | ENSC | Ensysce Biosciences, Inc. | 3.70M | -3.77% | 68,462 | 4.49M |
| 581 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.65M | -16.67% | 388,398 | 15.78K |
| 582 | CMND | Clearmind Medicine Inc. | 3.55M | -2.47% | 32,228 | - |
| 583 | OGEN | Oragenics, Inc. | 3.43M | -3.13% | 42,259 | - |
| 584 | PHGE | BiomX Inc. | 3.34M | -2.23% | 48,940 | - |
| 585 | HCWB | HCW Biologics Inc. | 3.32M | 0.80% | 32,685 | 422.03K |
| 586 | AZTR | Azitra, Inc. | 3.14M | -3.65% | 378,029 | 7.50K |
| 587 | ARTL | Artelo Biosciences, Inc. | 2.95M | -8.76% | 54,404 | - |
| 588 | BBLG | Bone Biologics Corporation | 2.88M | 3.55% | 29,911 | - |
| 589 | VRAX | Virax Biolabs Group Limited | 2.78M | 1.90% | 53,761 | 2.99K |
| 590 | CDT | CDT Equity Inc. | 2.66M | - | 11,789 | - |
| 591 | SCNI | Scinai Immunotherapeutics Ltd. | 2.64M | -5.63% | 15,702 | 1.15M |
| 592 | ONCO | Onconetix, Inc. | 2.57M | -4.07% | 39,719 | 1.22M |
| 593 | DRMA | Dermata Therapeutics, Inc. | 2.43M | -3.27% | 48,162 | - |
| 594 | GRI | GRI Bio, Inc. | 2.29M | -20.37% | 4,688,567 | - |
| 595 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.23M | 2.72% | 91,386 | 1.36M |
| 596 | BDRX | Biodexa Pharmaceuticals Plc | 1.95M | 0.43% | 92,951 | 104.90K |
| 597 | PBM | Psyence Biomedical Ltd. | 1.48M | 2.59% | 252,822 | - |
| 598 | ADTX | Aditxt, Inc. | 1.40M | -5.49% | 269,511 | 5.95K |
| 599 | MLEC | Moolec Science SA | 1.14M | -4.47% | 7,441 | 7.83M |
| 600 | ELAB | PMGC Holdings Inc. | 998.98K | -3.59% | 419,636 | 285.95K |